QR Kod

The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson’s Disease

As therapeutic trials target early stages of Parkinson’s disease (PD), appropriate patient selection based purely on clinical criteria poses significant challenges. Members of the Critical Path for Parkinson’s Consortium formally submitted documentation to the European Medicines Agency (EMA) support...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Diane Stephenson, Derek Hill, Jesse M. Cedarbaum, Maria Tome, Spiros Vamvakas, Klaus Romero, Daniela J. Conrado, David T. Dexter, John Seibyl, Danna Jennings, Timothy Nicholas, Dawn Matthews, Zhiyong Xie, Syed Imam, Paul Maguire, David Russell, Mark Forrest Gordon, Glenn T. Stebbins, Ed Somer, Jill Gallagher, Arthur Roach, Peter Basseches, Donald Grosset, Kenneth Marek
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publishing 2019-07-01
Seri Bilgileri:Journal of Parkinson’s Disease
Online Erişim:https://doi.org/10.3233/JPD-191648
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller